Platform
Features
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Stage
Employees
Links
Ben Bergo
9 members
8 members
5 members
4 members
3 members
Inceptive
5 followers
Vera Therapeutics
2 followers
Mineralys Therapeutics
1 follower
Slingshot Biosciences
Cepheid
Athelas
4 followers
Merck
193 followers
Immunome
Leapcure
Amgen
180 followers
Anthropic
39 followers
Discover companies